In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
486 News Items found
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
To Improve Immunotherapy, Researchers Look to Shift Immune Cells’ Access to Sugar

More sugar available for immune cells could mean better immune responses against cancer.
Dr. Diane Reidy-Lagunes sits at a desk with a microphone
Your Impact: Upcoming Events at MSK and Celebrating Cycle for Survival

Thank you to our donor community. Your commitment to supporting Memorial Sloan Kettering Cancer Center (MSK) is essential to advancing our mission.
A liquid being pipetted into a well plate.
Meet the 2026 Graduates of the Gerstner Sloan Kettering Graduate School

Fifteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 13, 2026, as part of Memorial Sloan Kettering’s 47th annual academic convocation.
Illustration of DNA with green wrench making adjustments to a nut on the double helix.
Science Byte
A Clean Break: Scientists Make Surprising Discoveries about DNA Repair

A study reveals unexpected insights into how cells prepare broken DNA strands to be rejoined, preventing mutations that can cause cancer.
Selwyn M. Vickers, MD, FACS
A Message From MSK’s President and CEO, Dr. Selwyn Vickers

In cancer care, firsts make a difference. At MSK, we are constantly improving how we help people with those important firsts. Dr. Selwyn Vickers writes about the latest developments at MSK and the encouraging evidence that we are making progress in our mission of ending cancer for life.
A researcher working in an MSK lab
MSK Research Highlights, December 16, 2025

New MSK research finds a way to package protein-degrading drugs called PROTACs into nanoparticles that target blood vessels within solid tumors; identifies genomic markers that predict whether precancerous blood conditions will turn into multiple myeloma; develops a data-driven approach that could catch lymphedema earlier; and shows that nurse-led palliative care delivered by phone could serve as a scalable model.
This screenshot from a video shows an 11-day-old mouse embryo with its internal organs highlighted in fluorescence.
Quantum Leap

MSK investigators are leading the way with approaches so bold they are like the difference between "a snapshot and a movie."
Molecular biologist John Petrini of the Sloan Kettering Institute.
Feature
Understanding the DNA-Damage “First Responders”: John Petrini at Work

Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.
Map of world showing where postdocs came from.
International Postdocs From 60 Countries Are Training at MSK in 2025

What inspires the outstanding young scientists who come from around the world to train at MSK?
Reicy Bobadilla stands in front of a window with the MSK logo on it
What You Should Know About Mesothelioma in Younger Patients

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.